RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재

      Sphingosine-1-Phosphate-Induced Migration and Differentiation of Human Mesenchymal Stem Cells to Smooth Muscle Cells

      한글로보기

      https://www.riss.kr/link?id=A82535277

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      국문 초록 (Abstract)

      중간엽 줄기세포의 이동과 분화는 손상된 조직의 재생을 위해 필수적이다. Sphingosine-1-phosphate (S1P)는 세포성장, 생존, 분화, 이동성 등 여러 가지 생명현상에 중요한 역할을 하는 생리활성 지...

      중간엽 줄기세포의 이동과 분화는 손상된 조직의 재생을 위해 필수적이다. Sphingosine-1-phosphate (S1P)는 세포성장, 생존, 분화, 이동성 등 여러 가지 생명현상에 중요한 역할을 하는 생리활성 지질이다. 본 연구에서는 인체 골수유래 중간엽 줄기세포의 이동과 세포분화에 대한 S1P의 영향을 조사하였다. S1P는 중간엽 줄기세포의 이동을 증가시켰으며 pertussis toxin의 전처리는 S1P에 의한 세포이동을 억제하였다. 본 결과는 S1P에 의한 세포이동과정에 Gi에 연결된 수용체가 관여함을 제시한다. S1P₁과 S1P₃ 수용체에 대한 길항제인 VPC23019의 전처리나 siRNA를 이용한 S1P₁ 수용체의 발현억제는 S1P에 의한 세포 내 칼슘 증가와 중간엽 줄기세포의 이동을 저해하였다. 또한, S1P의 처리는 중간엽 줄기세포에서 평활근세포의 표지유전자인 α-smooth muscle actin (α-SMA)의 발현을 증가시켰으며 VPC23019의 전처리는 S1P에 의한 α-SMA의 발현증가를 저해하였다. S1P는 중간엽 줄기세포에서 p38 mitogen-activated protein kinase (p38 MAPK)의 인산화를 촉진하였으며 p38 MAPK의 저해제인 SB202190의 전처리 또는 p38 MAPK의 dominant negative mutant의 과발현은 S1P에 의한 중간엽 줄기세포의 이동 α-SMA 발현증가를 억제하였다. 본 연구결과는 S1P가 S1P1-p38 MAPK 신호전달기전을 통해 중간엽 줄기세포의 이동과 평활근세포로의 분화를 촉진함으로써 중간엽 줄기세포를 이용한 조직재생에의 활용 가능성을 제시한다.

      더보기

      다국어 초록 (Multilingual Abstract)

      Migration and differentiation of mesenchymal stem cells are crucial for tissue regeneration in response to injury. Sphingosine-1-phosphate (S1P) is a bioactive lipid that regulates a variety of biological processes, including proliferation, survival, ...

      Migration and differentiation of mesenchymal stem cells are crucial for tissue regeneration in response to injury. Sphingosine-1-phosphate (S1P) is a bioactive lipid that regulates a variety of biological processes, including proliferation, survival, differentiation and motility. In the present study, we determined the role of S1P in migration and differentiation of human bone marrow-derived mesenchymal stem cells (BMSCs). S1P stimulated migration of BMSCs in a dose- and time-dependent manner, and pre-incubation of the cells with pertussis toxin completely abrogated S1P-induced migration, suggesting involvement of Gi-coupled receptors in S1P-induced cell migration. S1P elicited elevation of intracellular concentration of Ca<SUP>2+</SUP> ([Ca<SUP>2+</SUP>]i) and pretreatment with VPC23019, an antagonist of S1P₁/S1P₃, blocked S1P-induced migration and increase of [Ca<SUP>2+</SUP>]i. Small interfering RNA-mediated knockdown of endogenous S1P1 attenuated S1P-induced migration of BMSCs. Furthermore, S1P treatment induced expression of α-smooth muscle actin (α-SMA), a smooth muscle marker, and pretreatment with VPC23019 abrogated S1P-induced α-SMA expression. S1P induced phosphorylation of p38 mitogen-activated protein kinase (MAPK), and pretreatment of cells with SB202190, an inhibitor of p38 MAPK, or adenoviral overexpression of a dominant-negative mutant of the p38 MAPK blocked S1P-induced cell migration and α-SMA expression. Taken together, these results suggest that S1P stimulates migration and smooth muscle differentiation of BMSCs through an S1P1-p38 MAPK-dependent mechanism.

      더보기

      목차 (Table of Contents)

      • Introduction
      • Materials and Methods
      • Results
      • Discussion
      • Acknowledgement
      • Introduction
      • Materials and Methods
      • Results
      • Discussion
      • Acknowledgement
      • References
      • 초록
      더보기

      참고문헌 (Reference)

      1 Law, R. E., "Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia" 98 : 1897-1905, 1996

      2 Gabbiani, G, "The myofibroblast in wound healing and fibrocontractive diseases" 200 : 500-503, 2003

      3 Ponte, A. L., "The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities" 25 : 1737-1745, 2007

      4 Ponte, A. L., "The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities" 25 : 1737-1745, 2007

      5 Lepley, D., "The G protein-coupled receptor S1P2 regulates Rho/Rho kinase pathway to inhibit tumor cell migration" 65 : 3788-3795, 2005

      6 Sanchez, T, "Structural and functional characteristics of S1P receptors" 92 : 913-922, 2004

      7 Spiegel, S, "Sphingosine-1-phosphate: an enigmatic signalling lipid" 4 : 397-407, 2003

      8 Taha, T. A., "Sphingosine-1-phosphate receptors: receptor specificity versus functional redundancy" 1682 : 48-55, 2004

      9 Yamaguchi, H., "Sphingosine-1-phosphate receptor subtype-specific positive and negative regulation of Rac and haematogenous metastasis of melanoma cells" 374 : 715-722, 2003

      10 Yatomi, Y., "Sphingosine 1-phosphate, a bioactive sphingolipid abundantly stored in platelets, is a normal constituent of human plasma and serum" 121 : 969-973, 1997

      1 Law, R. E., "Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia" 98 : 1897-1905, 1996

      2 Gabbiani, G, "The myofibroblast in wound healing and fibrocontractive diseases" 200 : 500-503, 2003

      3 Ponte, A. L., "The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities" 25 : 1737-1745, 2007

      4 Ponte, A. L., "The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities" 25 : 1737-1745, 2007

      5 Lepley, D., "The G protein-coupled receptor S1P2 regulates Rho/Rho kinase pathway to inhibit tumor cell migration" 65 : 3788-3795, 2005

      6 Sanchez, T, "Structural and functional characteristics of S1P receptors" 92 : 913-922, 2004

      7 Spiegel, S, "Sphingosine-1-phosphate: an enigmatic signalling lipid" 4 : 397-407, 2003

      8 Taha, T. A., "Sphingosine-1-phosphate receptors: receptor specificity versus functional redundancy" 1682 : 48-55, 2004

      9 Yamaguchi, H., "Sphingosine-1-phosphate receptor subtype-specific positive and negative regulation of Rac and haematogenous metastasis of melanoma cells" 374 : 715-722, 2003

      10 Yatomi, Y., "Sphingosine 1-phosphate, a bioactive sphingolipid abundantly stored in platelets, is a normal constituent of human plasma and serum" 121 : 969-973, 1997

      11 Lockman, K, "Sphingosine 1-phosphate stimulates smooth muscle cell differentiation and proliferation by activating separate serum response factor co-factors" 279 : 42422-42430, 2004

      12 Kohno, T., "Sphingosine 1-phosphate promotes cell migration through the activation of Cdc42 in Edg-6/S1P4-expressing cells" 8 : 685-697, 2003

      13 Nincheri, P., "Sphingosine 1-phosphate induces differentiation of adipose tissue-derived mesenchymal stem cells towards smooth muscle cells" 66 : 1741-1754, 2009

      14 Park, K. S., "S1P stimulates chemotactic migration and invasion in OVCAR3 ovarian cancer cells" ACADEMIC PRESS INC ELSEVIER SCIENCE 356 (356): 239-244, 2007

      15 Kang, Y. J., "Role of c-jun N-terminal kinase in the PDGF-induced proliferation and migration of human adipose tissue-derived mesenchymal stem cells" WILEY-LISS 95 : 1135-1145, 2005

      16 Jaganathan, B. G., "Rho inhibition induces migration of mesenchymal stromal cells" 25 : 1966-1974, 2007

      17 Fox, J. M., "Recent advances into the understanding of mesenchymal stem cell trafficking" 137 : 491-502, 2007

      18 Hla,T, "Physiological and pathological actions of sphingosine 1-phosphate" 15 : 513-520, 2004

      19 Tomasek, J. J., "Myofibroblasts and mechano-regulation of connective tissue remodelling" 3 : 349-363, 2002

      20 Pittenger, M. F., "Multilineage potential of adult human mesenchymal stem cells" 284 : 143-147, 1999

      21 Dwyer, R. M., "Monocyte chemotactic protein-1 secreted by primary breast tumors stimulates migration of mesenchymal stem cells" 13 : 5020-5027, 2007

      22 Owens, G. K., "Molecular regulation of vascular smooth muscle cell differentiation in development and disease" 84 : 767-801, 2004

      23 Barry, F. P, "Mesenchymal stem cells: clinical applications and biological characterization" 36 : 568-584, 2004

      24 Short, B., "Mesenchymal stem cells" 34 : 565-571, 2003

      25 Annabi, B., "Matrix metalloproteinase regulation of sphingosine-1-phosphate-induced angiogenic properties of bone marrow stromal cells" 31 : 640-649, 2003

      26 Prockop,D.J, "Marrow stromal cells as stem cells for nonhematopoietic tissues" 276 : 71-74, 1997

      27 Wang, L., "MCP-1, MIP-1, IL-8 and ischemic cerebral tissue enhance human bone marrow stromal cell migration in interface culture" 7 : 113-117, 2002

      28 Huang, C., "MAP kinases and cell migration" 117 : 4619-4628, 2004

      29 Ishii, I., "Lysophospholipid receptors: signaling and biology" 73 : 321-354, 2004

      30 Lee, M. J., "Lysophosphatidic acid in malignant ascites stimulates migration of human mesenchymal stem cells" WILEY-LISS 104 : 499-510, 2008

      31 Wymann, M. P, "Lipid signalling in disease" 9 : 162-176, 2008

      32 Ji, J. F., "Interactions of chemokines and chemokine receptors mediate the migration of mesenchymal stem cells to the impaired site in the brain after hypoglossal nerve injury" 22 : 415-427, 2004

      33 Sugimoto, N., "Inhibitory and stimulatory regulation of Rac and cell motility by the G12/13-Rho and Gi pathways integrated downstream of a single G protein-coupled sphingosine-1-phosphate receptor isoform" 23 : 1534-1545, 2003

      34 Li, C., "Homing of bone marrow mesenchymal stem cells mediated by sphingosine 1-phosphate contributes to liver fibrosis" 50 : 1174-1183, 2009

      35 Chavakis, E., "Homing and engraftment of progenitor cells: A prerequisite for cell therapy" 45 : 514-522, 2008

      36 Forte, G., "Hepatocyte growth factor effects on mesenchymal stem cells:proliferation,migration,and differentiation.Stem Cells 24,23-33" 24 : 23-33, 2006

      37 Tamama, K., "Epidermal growth factor as a candidate for ex vivo expansion of bone marrow-derived mesenchymal stem cells" 24 : 686-695, 2006

      38 Liu, Y., "Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation" 106 : 951-961, 2000

      39 Goetzl, E. J, "Diversity of cellular receptors and functions for the lysophospholipid growth factors lysophosphatidic acid and sphingosine 1-phosphate" 12 : 1589-1598, 1998

      40 Meriane, M., "Cooperation of matrix metalloproteinases with the RhoA/Rho kinase and mitogen-activated protein kinase kinase-1/extracellular signal-regulated kinase signaling pathways is required for the sphingosine-1-phosphate-induced mobilization of marrow-derived stromal cells" 24 : 2557-2565, 2006

      41 Chamberlain, G., "Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing" 25 : 2739-2749, 2007

      42 Lee, R. H., "Characterization and expression analysis of mesenchymal stem cells from human bone marrow and adipose tissue" KARGER 14 : 311-324, 2004

      43 Fiedler, J., "BMP-2, BMP-4, and PDGF-bb stimulate chemotactic migration of primary human mesenchymal progenitor cells" 87 : 305-312, 2002

      44 Huang, S., "Apoptosis signaling pathway in T cells is composed of ICE/Ced-3 family proteases and MAP kinase kinase 6b" 6 : 739-749, 1997

      45 Lee, R. H., "A subset of human rapidly self-renewing marrow stromal cells preferentially engraft in mice" 107 : 2153-2161, 2006

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2027 평가예정 재인증평가 신청대상 (재인증)
      2021-01-01 평가 등재학술지 유지 (재인증) KCI등재
      2018-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2015-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2011-08-03 학술지명변경 외국어명 : Korean Journal of Life Science -> Journal of Life Science KCI등재
      2011-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2009-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2007-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2004-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      2003-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2001-07-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 0.37 0.37 0.42
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.43 0.43 0.774 0.09
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼